Insight

The latest clinical and preclinical developments in anticancer vaccines – Cell Stress and Immunity Lab

Francisca Borges/Linkedin

Oct 17, 2024, 04:58

The latest clinical and preclinical developments in anticancer vaccines – Cell Stress and Immunity Lab

Cell Stress and Immunity Lab shared on X about a recent paper by Francisca Borges et al. published in OncoImmunology:

“Happy to share our review of the latest clinical and preclinical developments in anticancer vaccines utilizing dendritic cells (DCs). Thanks, Francisca Borges and Raquel Laureano for heavy lifting.”

“Trial watch: anticancer vaccination with dendritic cells”

Authors: Francisca Borges, Raquel Laureano, Isaure Vanmeerbeek, Jenny Sprooten, Octavie Demeulenaere, Jannes Govaerts, Lisa Kinget, Saurabh Saraswat, Stefan Naulaerts and Abhishek Garg et al..

More posts featuring Cell Stress and Immunity Lab on oncodaily.com.

Abhishek Garg anticancer vaccines cancer Cell Stress and Immunity (CSI) Lab csi Francisca Borges Isaure Vanmeerbeek Jannes Govaerts Jenny Sprooten Lisa Kinget Octavie Demeulenaere OncoDaily OncoImmunology Oncology Raquel Laureano Saurabh Saraswat Stefan Naulaerts

Richard Gere and Alejandra Gere to Join Second Global OncoThon on February 15 for Fight Against Childhood Cancer

Mesothelioma Guideline Updates from ASCO 2024: Key Advances in Diagnosis and Treatment

Oncologist Near Me - Lynn Schuchter: A Pioneering Leader in Cancer Care and Melanoma Research

NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%

Stanley Tucci and Throat Cancer: How He Went Against, How He Survived, and More